Literature DB >> 29074546

Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results.

James Brown1,2,3, Kartik Kumar4,3, Jacob Reading5, Jennifer Harvey1, Saraswathi Murthy1, Santino Capocci1, Susan Hopkins1, Suranjith Seneviratne1, Ian Cropley1, Marc Lipman1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29074546     DOI： 10.1183/13993003.01267-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Evaluation of QuantiFERON-TB Gold Plus on Liaison XL in a Low-Tuberculosis-Incidence Setting.

Authors:  E De Maertelaere; S Vandendriessche; B Verhasselt; L Coorevits; E André; E Padalko; J Boelens
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

2.  In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production.

Authors:  Alessandra Imeneo; Grazia Alessio; Andrea Di Lorenzo; Laura Campogiani; Alessandra Lodi; Filippo Barreca; Marta Zordan; Virginia Barchi; Barbara Massa; Simona Tedde; Angela Crea; Pietro Vitale; Ilaria Spalliera; Mirko Compagno; Luigi Coppola; Luca Dori; Vincenzo Malagnino; Elisabetta Teti; Massimo Andreoni; Loredana Sarmati; Marco Iannetta
Journal:  Life (Basel)       Date:  2022-02-07

3.  Beyond QuantiFERON-TB Results, the Added Value of a Weak Mitogen Response.

Authors:  Marine Jacquier; Christine Binquet; Catherine Manoha; Sylvain Audia; Anne-Laure Simonet-Lamm; Alice Casenaz; Amadou-Khalilou Sow; Lionel Piroth; Mathieu Blot
Journal:  Front Med (Lausanne)       Date:  2022-05-30

4.  The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers.

Authors:  Jae Hyeon Park; Namhee Kim; Hyunwoong Park; Taek Soo Kim; Sang-Won Park; Eun Youn Roh; Jong Hyun Yoon; Sue Shin
Journal:  PLoS One       Date:  2020-06-30       Impact factor: 3.240

Review 5.  Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management.

Authors:  Sasha R Fehily; Aysha H Al-Ani; Jonathan Abdelmalak; Clarissa Rentch; Eva Zhang; Justin T Denholm; Douglas Johnson; Siew C Ng; Vishal Sharma; David T Rubin; Peter R Gibson; Britt Christensen
Journal:  Aliment Pharmacol Ther       Date:  2022-05-20       Impact factor: 9.524

6.  Evaluation of the Fully Automated Chemiluminescence Analyzer Liaison XL for the Performance of the QuantiFERON-TB Gold Plus Assay in an Area with a Low Incidence of Tuberculosis.

Authors:  Miguel Fernández-Huerta; Clara Moreto; Neus Vila-Olmo; Erika-Inés García de Cara; María-Celeste Basaez; Miguel Santín; Fernando Alcaide
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

7.  The Relationship between Pre-Pandemic Interferon Gamma Release Assay Test Results and COVID-19 Infection: Potential Prognostic Value of Indeterminate IFN-γ Release Assay Results.

Authors:  Sermin Borekci; Fatma Gulsum Karakas; Serhat Sirekbasan; Bahar Kubat; Rıdvan Karaali; Gunay Can; Bekir Sami Kocazeybek; Bilun Gemicioglu
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-07-31       Impact factor: 2.471
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.